Shares

26 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2022

May 12, 2023

BUY
$7.35 - $10.63 $335,652 - $485,440
45,667 New
45,667 $375,000
Q1 2022

May 09, 2022

SELL
$7.35 - $10.63 $335,652 - $485,440
-45,667 Closed
0 $0
Q4 2021

Mar 09, 2022

BUY
$4.19 - $9.56 $191,344 - $436,576
45,667 New
45,667 $437,000
Q3 2021

Nov 14, 2022

BUY
$3.56 - $4.64 $162,574 - $211,894
45,667 New
45,667 $212,000
Q3 2021

Nov 05, 2021

SELL
$3.56 - $4.64 $162,574 - $211,894
-45,667 Closed
0 $0
Q2 2021

Aug 15, 2022

BUY
$3.95 - $5.41 $180,384 - $247,058
45,667 New
45,667 $197,000
Q2 2021

Aug 10, 2021

SELL
$3.95 - $5.41 $1.56 Million - $2.14 Million
-395,767 Closed
0 $0
Q1 2021

May 09, 2022

BUY
$4.52 - $7.8 $1.79 Million - $3.09 Million
395,767 New
395,767 $2.09 Million
Q1 2021

May 07, 2021

SELL
$4.52 - $7.8 $2.08 Million - $3.58 Million
-459,569 Closed
0 $0
Q4 2020

Mar 02, 2021

BUY
$4.37 - $9.46 $2.01 Million - $4.35 Million
459,569 New
459,569 $3.24 Million
Q4 2020

Feb 10, 2021

SELL
$4.37 - $9.46 $1.8 Million - $3.89 Million
-411,687 Closed
0 $0
Q3 2020

Nov 12, 2021

BUY
$8.56 - $26.93 $3.52 Million - $11.1 Million
411,687 New
411,687 $3.73 Million
Q3 2020

Nov 10, 2020

SELL
$8.56 - $26.93 $3.56 Million - $11.2 Million
-416,460 Closed
0 $0
Q2 2020

Aug 13, 2021

BUY
$21.21 - $31.55 $8.83 Million - $13.1 Million
416,460 New
416,460 $11.4 Million
Q2 2020

Aug 07, 2020

SELL
$21.21 - $31.55 $8.69 Million - $12.9 Million
-409,804 Closed
0 $0
Q1 2020

May 07, 2021

BUY
$18.43 - $38.04 $7.55 Million - $15.6 Million
409,804 New
409,804 $9.02 Million
Q1 2020

May 08, 2020

SELL
$18.43 - $38.04 $7.55 Million - $15.6 Million
-409,804 Closed
0 $0
Q4 2019

Mar 03, 2020

BUY
$29.6 - $43.71 $12.1 Million - $17.9 Million
409,804 New
409,804 $15.5 Million
Q4 2019

Feb 12, 2020

SELL
$29.6 - $43.71 $3.18 Million - $4.7 Million
-107,558 Closed
0 $0
Q3 2019

Nov 13, 2020

BUY
$29.87 - $42.22 $3.21 Million - $4.54 Million
107,558 New
107,558 $3.32 Million
Q2 2019

Aug 09, 2019

SELL
$31.16 - $39.46 $311,600 - $394,600
-10,000 Closed
0 $0
Q4 2018

Mar 04, 2019

BUY
$23.57 - $32.33 $235,700 - $323,300
10,000 New
10,000 $236,000
Q4 2018

Feb 08, 2019

SELL
$23.57 - $32.33 $235,700 - $323,300
-10,000 Closed
0 $0
Q3 2018

Nov 12, 2019

BUY
$22.5 - $39.35 $225,000 - $393,500
10,000 New
10,000 $306,000
Q3 2018

Nov 09, 2018

SELL
$22.5 - $39.35 $225,000 - $393,500
-10,000 Closed
0 $0
Q2 2018

Aug 12, 2019

BUY
$26.0 - $29.9 $260,000 - $299,000
10,000 New
10,000 $299,000

Others Institutions Holding TCDA

About Tricida, Inc.


  • Ticker TCDA
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 55,668,900
  • Market Cap $557K
  • Description
  • Tricida, Inc. operates as a pharmaceutical company. It focuses on the development and commercialization of veverimer (TRC101), a non-absorbed orally-administered polymer that has completed Phase III trial to treat metabolic acidosis in patients with chronic kidney disease by binding and removing acid from the gastrointestinal track. The company ...
More about TCDA
Track This Portfolio

Track Norges Bank Portfolio

Follow Norges Bank and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Norges Bank, based on Form 13F filings with the SEC.

News

Stay updated on Norges Bank with notifications on news.